Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai

International Urology and Nephrology

Volumn 41, Issue 4, 2009, Pages 855-864

  Wen, Hui ^a   Ding, Qiang ^a   Fang, Zu Jun ^a   Xia, Guo Wei ^a   Fang, Jie ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Bladder neoplasms; Risk polymorphisms; Single nucleotide; Tobacco

Indexed keywords

ADENINE; ASPARTIC ACID; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOSINE; GENE PRODUCT; GLUTAMINE; HISTIDINE; LYSINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) 1; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP C PROTEIN; XERODERMA PIGMENTOSUM TYPE G PROTEIN; XRCC1 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CHINA; CHINESE; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; CHINA; COMORBIDITY; CONFIDENCE INTERVALS; DNA, NEOPLASM; DNA-BINDING PROTEINS; ETHNIC GROUPS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROBABILITY; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SMOKING; SURVIVAL ANALYSIS; URBAN POPULATION; URINARY BLADDER NEOPLASMS;

EID: 77954563856     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9560-y     Document Type: Article

References (28)

1. Franekova M, Halasova E, Bukovska E, Luptak J, Dobrota D (2008) Gene polymorphisms in bladder cancer. Urol Oncol 26:1-8. doi:10.1016/j.urolonc.2006. 10.011
2. Yang L, Parkin DM, Li LD, Chen YD, Bray F (2004) Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 90:2157-2166
3. Huncharek M, Geschwind JF, Witherspoon B et al (2000) Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials. J Clin Epidemiol 53:676-680. doi:10.1016/S0895-4356(99)00203-6 (Pubitemid 30609619)
4. Downing A, Forman D, Gilthorpe MS, Edwards KL, Manda SO (2008) Joint disease mapping using six cancers in the Yorkshire region of England. Int J Health Geogr 7:41. doi:10.1186/1476-072X-7-41
5. Jemal A, Ward E, Thun MJ (2007) Recent trends in breast cancer incidence rates by age and tumor characteristics among US women. Breast Cancer Res 9:R28. doi:10.1186/bcr1672 (Pubitemid 350214681)
6. Mao Z, Bozzella M, Seluanov A, Gorbunova V (2008) DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle 7:2902-2906
7. Christmann M, Tomicic MT, Roos WP, Kaina B (2003) Mechanisms of human DNA repair: an update. Toxicology 193:3-34. doi:10.1016/S0300-483X(03)00287-7 (Pubitemid 37340141)
8. Zasimauskas D, Zekonis G (2008) Effect of smoking on neutrophil oxidative metabolism. Medicina 443:195-200 (in Lithuanian)
9. Xu G, Herzig M, Rotrekl V, Walter CA (2008) Base-excision repair, aging and health span. Mech Ageing Dev 129:366-382. doi:10.1016/j.mad.2008.03.001
10. Chen CH, Shun CT, Huang KH et al (2007) Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int 100:281-286. doi:10.1111/j.1464-410X.2007.06873.x
11. Wu XF, Dzenis YA (2006) Guided self-assembly of diblock copolymer thin films on chemically patterned substrates. J Chem Phys 125:174707. doi:10.1063/1.2363982 (Pubitemid 44707851)
12. Lin J, Swan GE, Shields PG et al (2007) Mutagen sensitivity and genetic variants in nucleotide-excision repair pathway: genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev 16:2065-2071. doi:10.1158/1055-9965.EPI-06-1041 (Pubitemid 47621181)
13. Sanyal S, De Verdier PJ, Steineck G et al (2007) Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms. Acta Oncol 46:31-41. doi:10.1080/02841860600812693
14. García-Closas M, Malats N, Real FX et al (2006) Genetic variation in the nucleotide-excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 15:536-542. doi:10.1158/1055-9965.EPI-05-0749
15. Zhu Y, Yang H, Chen Q et al (2008) Modulation of DNA damage/DNA repair capacity by XPC polymorphisms. DNA Repair (Amst) 7:141-148. doi:10.1016/j. dnarep.2007.08. 006
16. Chen Z, Yang J, Wang G, Song B, Li J, Xu Z (2007) Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression. Cancer Res 67:4578-4585. doi:10.1158/0008-5472.CAN-06-0877 (Pubitemid 46910162)
17. Gowda S, Kumaran M, Suma BS, Rao MR (2007) Single nucleotide polymorphism analysis of the nucleotide-exci-sion repair genes XPC, XPA, and XPG in the Indian population. Hum Biol 79:545-562
18. Dworaczek H, Xiao W (2007) Xeroderma pigmentosum: a glimpse into nucleotide-excision repair, genetic instability, and cancer. Crit Rev Oncog 13:159-177
19. Arizono K, Osada Y, Kuroda Y (2008) DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn J Clin Oncol 38:186-191. doi:10.1093/jjco/hym176 (Pubitemid 351419742)
20. Li M, Yin Z, Guan P et al (2008) XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers. Lung Cancer 62:145-151. doi:10.1016/j.lungcan.2008.03.002
21. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE (2006) Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 15:2537-2541. doi:10.1158/1055-9965.EPI-06-0288 (Pubitemid 46048318)
22. Horikawa Y, Gu J, Wu X (2008) Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions. Curr Opin Urol 18:493-498
23. Srivastava DS, Mandhani A, Mittal RD (2008) Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India. Arch Toxicol 82:633-639. doi:10.1007/s00204-007-0276-4
24. Altayli E, Gunes S, Yilmaz AF, Goktas S, Bek Y (2008) CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population. Int Urol Nephrol. [Epub ahead of print] Aug 9
25. Mackie SJ, Cooper AJ (2008) Development of a new 3-dimensional in vitro superficial bladder cancer model. Eur Urol Suppl 7:209. doi:10.1016/S1569- 9056(08)60551-5
26. Jamieson D, Wilson K, Pridgeon S et al (2007) NAD(P)H:quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism. Clin Cancer Res 13:1584-1590. doi:10.1158/1078-0432.CCR-06-1416 (Pubitemid 46450451)
27. Sukata T, Ozaki K, Uwagawa S et al (2000) Organ-specific, carcinogen-induced increases in cell proliferation in p53-deficient mice. Cancer Res 60:74-79
28. Sakano S, Kumar R, Larsson P et al (2006) A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmus-cle-invasive neoplasms of the urinary bladder. BJU Int 97:847-851. doi:10.1111/j.1464-410X.2005.05994.x (Pubitemid 43383526)